UBS’s Silver Standard Resources SSRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$48K Sell
7,900
-3,800
-32% -$32.4K ﹤0.01% 6902
2014
Q2
$101K Buy
11,700
+2,300
+24% +$19.9K ﹤0.01% 5938
2014
Q1
$93K Sell
9,400
-10,300
-52% -$96.7K ﹤0.01% 6086
2013
Q4
$137K Buy
19,700
+10,100
+105% +$61.1K ﹤0.01% 5714
2013
Q3
$59K Buy
9,600
+5,500
+134% +$41.2K ﹤0.01% 6665
2013
Q2
$26K Buy
+4,100
New +$30.2K ﹤0.01% 7599

Other funds holding SSRI

UBS's SSRI Position: Q3 2014 in Review

UBS reduced its Silver Standard Resources (SSRI) stake by 25% in Q3 2014, selling an estimated $488K and leaving 172,074 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3543.

UBS first reported a position in SSRI in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.99M in Q2 2014. 98 funds tracked by Wall St. Rank hold SSRI as of Q3 2014.

  • UBS held 172,074 shares of Silver Standard Resources worth $1.05M as of Q3 2014.
  • UBS sold 57,229 Silver Standard Resources shares in Q3 2014, an estimated $488K.
  • Silver Standard Resources made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3543 holding.
  • UBS first reported a position in Silver Standard Resources in Q2 2013 and has held it in 6 quarters since.
  • UBS's Silver Standard Resources position peaked at $1.99M in Q2 2014.
  • 98 funds tracked by Wall St. Rank held Silver Standard Resources as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.